Variant report

Variant	esv3514390
Chromosome Location	chr6:150643420-150647946
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:150644374-150644606	K562	blood:	n/a	n/a
2	BHLHE40	chr6:150644360-150644691	K562	blood:	n/a	n/a
3	CCNT2	chr6:150644328-150644856	K562	blood:	n/a	n/a
4	CEBPB	chr6:150643567-150643852	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
5	CEBPB	chr6:150644193-150644767	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
6	CEBPB	chr6:150644288-150644667	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
7	CEBPB	chr6:150643604-150643721	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr6:150644321-150644649	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
9	CEBPB	chr6:150644380-150644520	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
10	CEBPB	chr6:150644135-150644819	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
11	CEBPB	chr6:150644310-150644748	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
12	CEBPB	chr6:150643562-150643891	MCF-7	breast:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
13	CEBPB	chr6:150646083-150646753	ECC-1	luminal epithelium:	n/a	chr6:150646173-150646185
14	CEBPB	chr6:150644140-150644809	HCT-116	colon:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
15	CEBPB	chr6:150644234-150644757	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
16	CEBPB	chr6:150644307-150644671	Hela-S3	cervix:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
17	CEBPB	chr6:150644185-150644801	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
18	CEBPB	chr6:150644183-150644674	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
19	CEBPB	chr6:150643557-150643916	HepG2	liver:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
20	CEBPB	chr6:150644243-150644698	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
21	CEBPB	chr6:150644337-150644550	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
22	CEBPB	chr6:150644223-150644687	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
23	CEBPB	chr6:150644273-150644665	H1-hESC	embryonic stem cell:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
24	CEBPB	chr6:150644348-150644705	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
25	CEBPB	chr6:150644290-150644662	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
26	CEBPB	chr6:150643545-150643910	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
27	CEBPB	chr6:150644288-150644668	IMR90	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
28	CEBPD	chr6:150644335-150644738	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
29	CEBPD	chr6:150644232-150644737	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
30	CEBPD	chr6:150644359-150644546	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
31	CUX1	chr6:150644179-150644518	K562	blood:	n/a	n/a
32	E2F4	chr6:150646461-150646593	MCF10A-Er-Src	breast:	n/a	n/a
33	EBF1	chr6:150645966-150646161	GM12878	blood:	n/a	chr6:150646075-150646086 chr6:150646074-150646087 chr6:150645998-150646007 chr6:150645997-150646007
34	EP300	chr6:150645060-150645682	ECC-1	luminal epithelium:	n/a	n/a
35	EP300	chr6:150645966-150646890	ECC-1	luminal epithelium:	n/a	chr6:150646251-150646267
36	EP300	chr6:150645059-150646945	ECC-1	luminal epithelium:	n/a	chr6:150646251-150646267
37	EP300	chr6:150644266-150644689	K562	blood:	n/a	n/a
38	ESR1	chr6:150646084-150646662	ECC-1	luminal epithelium:	n/a	n/a
39	ESR1	chr6:150646029-150646693	ECC-1	luminal epithelium:	n/a	n/a
40	ESR1	chr6:150646012-150646673	ECC-1	luminal epithelium:	n/a	n/a
41	ESR1	chr6:150645157-150645569	ECC-1	luminal epithelium:	n/a	n/a
42	ESR1	chr6:150645115-150645564	ECC-1	luminal epithelium:	n/a	n/a
43	ESR1	chr6:150645197-150645679	ECC-1	luminal epithelium:	n/a	n/a
44	FOS	chr6:150646443-150646504	MCF10A-Er-Src	breast:	n/a	n/a
45	FOXM1	chr6:150645885-150647000	ECC-1	luminal epithelium:	n/a	n/a
46	FOXM1	chr6:150645031-150645797	ECC-1	luminal epithelium:	n/a	n/a
47	FOXM1	chr6:150645976-150646850	ECC-1	luminal epithelium:	n/a	n/a
48	GATA2	chr6:150644254-150644641	K562	blood:	n/a	chr6:150644542-150644555 chr6:150644308-150644319
49	GATA2	chr6:150644272-150644652	K562	blood:	n/a	chr6:150644542-150644555 chr6:150644308-150644319
50	HEY1	chr6:150647667-150647889	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:150638163..150639671-chr6:150643884..150646332,2	MCF-7	breast:
2	chr6:150642041..150644950-chr6:150645013..150647968,3	K562	blood:
3	chr12:120729257..120730114-chr6:150647863..150648380,2	Hela-S3	cervix:
4	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
5	chr6:150500428..150502661-chr6:150644242..150645820,2	K562	blood:
6	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
7	chr6:150514785..150516493-chr6:150643803..150645499,2	K562	blood:
8	chr6:150644840..150646705-chr6:150652961..150654511,2	K562	blood:
9	chr6:150586437..150588677-chr6:150642579..150644863,2	K562	blood:
10	chr6:150637450..150641855-chr6:150642003..150645154,6	K562	blood:
11	chr6:150630670..150634449-chr6:150639443..150643580,5	K562	blood:

Variant related genes	Relation type
RNU4-7P	TF binding region
ENSG00000202538	chromatin interactions
ENSG00000201628	chromatin interactions

Extended variants
information (count: 208 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:208 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs77854963	chr6:150643420-150643421	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs554392267	chr6:150643421-150643422	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs561068722	chr6:150643424-150643425	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs529997001	chr6:150643430-150643431	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs190717122	chr6:150643432-150643433	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs538365090	chr6:150643435-150643436	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs536868142	chr6:150643473-150643474	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs1890521	chr6:150643476-150643477	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs576728312	chr6:150643568-150643569	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs182912900	chr6:150643576-150643577	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs558190632	chr6:150643589-150643590	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs2153205	chr6:150643601-150643602	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs564928473	chr6:150643610-150643611	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs62441217	chr6:150643640-150643641	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs112438617	chr6:150643697-150643698	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs143814150	chr6:150643708-150643709	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs1890522	chr6:150643730-150643731	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs186463552	chr6:150643735-150643736	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs558187176	chr6:150643792-150643793	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs115946505	chr6:150643828-150643829	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs540716346	chr6:150643898-150643899	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs561263297	chr6:150643948-150643949	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs560916365	chr6:150644015-150644016	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs12527319	chr6:150644030-150644031	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs542293723	chr6:150644033-150644034	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs543675273	chr6:150644059-150644060	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs371129782	chr6:150644078-150644079	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs532306926	chr6:150644084-150644085	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs551321349	chr6:150644093-150644094	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs147250743	chr6:150644142-150644143	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs527765415	chr6:150644145-150644146	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs559070282	chr6:150644161-150644162	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs544054414	chr6:150644183-150644184	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs563927216	chr6:150644184-150644185	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs116487057	chr6:150644190-150644191	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs528067791	chr6:150644198-150644199	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs190837116	chr6:150644230-150644231	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs544565284	chr6:150644240-150644241	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs183841679	chr6:150644248-150644249	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs532843717	chr6:150644260-150644261	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs73779957	chr6:150644268-150644269	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs556766671	chr6:150644269-150644270	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs569922353	chr6:150644277-150644278	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs140779037	chr6:150644283-150644284	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs558723582	chr6:150644285-150644286	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs188020143	chr6:150644286-150644287	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs144727566	chr6:150644377-150644378	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs554291635	chr6:150644380-150644381	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs9384387	chr6:150644384-150644385	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs151287541	chr6:150644395-150644396	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Pancreatic cancer	17952125	CNVD
Developmental delay	21147756	CNVD

Chromatin state (count:65 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150641200-150645000	Enhancers	K562	blood
2	chr6:150641800-150644400	Weak transcription	Left Ventricle	heart
3	chr6:150642000-150646200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
4	chr6:150642000-150648200	Weak transcription	Aorta	Aorta
5	chr6:150642000-150648400	Weak transcription	Right Ventricle	heart
6	chr6:150642200-150643600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr6:150642600-150646400	Enhancers	Fetal Muscle Leg	muscle
8	chr6:150642600-150647400	Enhancers	Psoas Muscle	Psoas
9	chr6:150642800-150644800	Enhancers	Placenta	Placenta
10	chr6:150642800-150646600	Enhancers	Adipose Nuclei	Adipose
11	chr6:150643200-150643600	Enhancers	Fetal Muscle Trunk	muscle
12	chr6:150643200-150643600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
13	chr6:150643200-150643600	Enhancers	Spleen	Spleen
14	chr6:150643200-150644800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr6:150643200-150646200	Enhancers	Lung	lung
16	chr6:150643400-150644200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
17	chr6:150643400-150644600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
18	chr6:150643600-150643800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr6:150643600-150644200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr6:150643600-150645800	Weak transcription	Spleen	Spleen
21	chr6:150643600-150646800	Enhancers	Skeletal Muscle Female	skeletal muscle
22	chr6:150643800-150648400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr6:150644000-150644200	Bivalent Enhancer	HUVEC	blood vessel
24	chr6:150644000-150644600	Enhancers	Placenta Amnion	Placenta Amnion
25	chr6:150644200-150646400	Enhancers	Fetal Muscle Trunk	muscle
26	chr6:150644200-150646800	Enhancers	Skeletal Muscle Male	skeletal muscle
27	chr6:150644400-150644800	Enhancers	Left Ventricle	heart
28	chr6:150644600-150645200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr6:150644800-150646000	Weak transcription	Left Ventricle	heart
30	chr6:150645000-150647800	Weak transcription	K562	blood
31	chr6:150645200-150645600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr6:150645200-150645600	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr6:150645200-150645600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr6:150645200-150646400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr6:150645200-150646800	Enhancers	HMEC	breast
36	chr6:150645200-150647200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr6:150645400-150647000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr6:150645600-150646400	Enhancers	Primary hematopoietic stem cells	blood
39	chr6:150645600-150646400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr6:150645600-150646600	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr6:150645600-150646800	Enhancers	NHEK	skin
42	chr6:150645600-150647200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr6:150645600-150647600	Weak transcription	Cortex derived primary cultured neurospheres	brain
44	chr6:150645600-150663000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr6:150645800-150646200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
46	chr6:150645800-150646400	Enhancers	Spleen	Spleen
47	chr6:150645800-150646600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr6:150646000-150646400	Enhancers	Left Ventricle	heart
49	chr6:150646200-150646400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr6:150646200-150646400	Enhancers	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links